Dr. Nabil Thomas Makhlouf, MD

Dr. Makhlouf practices at The Southeast Permanente Medical Group in Atlanta, Georgia.

Dr. Makhlouf's NPI, 1023496239, was assigned on May 8, 2015. Dr. Makhlouf holds Illinois license 036152691.

Dr. Makhlouf's primary practice is The Southeast Permanente Medical Group, at 9 Piedmont NE Ctr, Atlanta, GA 30305 in Fulton County. The practice phone is (404) 364-3821.

Dr. Makhlouf's primary practice is The Southeast Permanente Medical Group in Atlanta, Georgia. The medical group on file is The Southeast Permanente Medical Group. Dmand AI also links Dr. Makhlouf to 4 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makhlouf practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Makhlouf's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Makhlouf is licensed in Illinois.

CMS data shows 481 Medicare services from Dr. Makhlouf across 12 procedure codes in 2024, for 212 Medicare patients. Medicare paid $22,275 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Dr. Makhlouf in 2024. The largest group is 75 to 84, with 87 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Makhlouf's median patient age at 62, with 59% women.

In 2024, Dr. Makhlouf wrote 706 Medicare Part D claims for 168 patients. 94% of them were for generic drugs. CMS names the drug for 522 of them, across 13 drugs with 11 or more claims each, at $23,849 in total drug cost. In 2023, CMS named 588 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Makhlouf for performance year 2024, reported as part of a group. Dr. Makhlouf accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Makhlouf from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $111.